Filing Details
- Accession Number:
- 0001567619-18-000239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-09 16:27:06
- Reporting Period:
- 2018-08-07
- Accepted Time:
- 2018-08-09 16:27:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514980 | Brian Mueller | 105 Digital Drive Novato CA 94949 | Svp, Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-07 | 1,718 | $28.23 | 14,093 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-07 | 782 | $28.23 | 14,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-07 | 2,500 | $104.50 | 12,375 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2018-08-07 | 1,718 | $0.00 | 1,718 | $28.23 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2018-08-07 | 782 | $0.00 | 782 | $28.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-12-01 | 2021-05-30 | No | 4 | M | Direct |
| 6,709 | 2011-12-01 | 2021-05-30 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on March 9, 2018.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
